Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects
Clinical trial NCT02223000 · COMPLETED
Trial details
- NCT number
- NCT02223000
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1998-03-01
- Primary completion
- 1998-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.